Paper25548434
Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.
Umare V and 6 others. Mediators Inflamm, 2014. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients. Papers, record 25548434. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25548434
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation | Major topic |
| Interleukin-1beta | Major topic |
| Interleukin-6 | Major topic |
| Lupus Erythematosus, Systemic | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Adult | |
| Autoantibodies | |
| Case-Control Studies | |
| Cohort Studies | |
| Cytokines | |
| Female | |
| Humans | |
| India | |
| Inflammation | |
| Inflammation Mediators | |
| Male | |
| Severity of Illness Index |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10733469 | Cytokines and systemic lupus erythematosus. | Ann Rheum Dis | 2000 | https://conductscience.org/library/papers/10733469 | PubMed |
| 2 | 24706988 | The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. | Rheumatology (Oxford) | 2014 | https://conductscience.org/library/papers/24706988 | PubMed |
| 3 | 12147202 | Interleukin-1--a major pleiotropic cytokine in tumor-host interactions. | Semin Cancer Biol | 2002 | https://conductscience.org/library/papers/12147202 | PubMed |
| 4 | 12613582 | Involvement of cytokines in the pathogenesis of systemic lupus erythematosus. | Adv Exp Med Biol | 2003 | https://conductscience.org/library/papers/12613582 | PubMed |
| 5 | 12604793 | Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12604793 | PubMed |
| 6 | 12823847 | SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. | Arthritis Res Ther | 2003 | https://conductscience.org/library/papers/12823847 | PubMed |
| 7 | 14989423 | The IL-1 family and inflammatory diseases. | Clin Exp Rheumatol | 2002 | https://conductscience.org/library/papers/14989423 | PubMed |
| 8 | 15067061 | Cytokine dysregulation induced by apoptotic cells is a shared characteristic of macrophages from nonobese diabetic and systemic lupus erythematosus-prone mice. | J Immunol | 2004 | https://conductscience.org/library/papers/15067061 | PubMed |
| 9 | 15230289 | Rationale for interleukin-6 blockade in systemic lupus erythematosus. | Lupus | 2004 | https://conductscience.org/library/papers/15230289 | PubMed |
| 10 | 2584702 | Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. | J Immunol | 1989 | https://conductscience.org/library/papers/2584702 | PubMed |
| 11 | 8445045 | Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. | J Clin Immunol | 1993 | https://conductscience.org/library/papers/8445045 | PubMed |
| 12 | 7731137 | Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. | Kidney Int | 1995 | https://conductscience.org/library/papers/7731137 | PubMed |
| 13 | 9324032 | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. | Arthritis Rheum | 1997 | https://conductscience.org/library/papers/9324032 | PubMed |
| 14 | 9607638 | Renal expression of IL-6 and TNFalpha genes in lupus nephritis. | Lupus | 1998 | https://conductscience.org/library/papers/9607638 | PubMed |
| 15 | 9641506 | Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. | Clin Rheumatol | 1998 | https://conductscience.org/library/papers/9641506 | PubMed |
| 16 | 9890104 | Measures of disease activity and damage in SLE. | Baillieres Clin Rheumatol | 1998 | https://conductscience.org/library/papers/9890104 | PubMed |
| 17 | 15732282 | Cytokine expression in lupus kidneys. | Lupus | 2005 | https://conductscience.org/library/papers/15732282 | PubMed |
| 18 | 15897306 | Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia. | Ann Rheum Dis | 2005 | https://conductscience.org/library/papers/15897306 | PubMed |
| 19 | 16150407 | New treatments for SLE: cell-depleting and anti-cytokine therapies. | Best Pract Res Clin Rheumatol | 2005 | https://conductscience.org/library/papers/16150407 | PubMed |
| 20 | 17067309 | Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. | Immunology | 2006 | https://conductscience.org/library/papers/17067309 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42699060 | Blockade of NLRP3 alleviates systemic lupus erythematosus-induced osteoporosis through dual modulation of osteogenesis and osteoclastogenesis. | Bone Rep | 2026 | https://conductscience.org/library/papers/42699060 | PubMed |
| 42483409 | Effects of TNF-α, IL-1β and IL-2 on regulatory T cells in children with idiopathic nephrotic syndrome. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42483409 | PubMed |
| 42312209 | Stress-induced IL-6 regulation in pediatric bone growth disorders: current insights and therapeutic strategies. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42312209 | PubMed |
| 42183268 | Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183268 | PubMed |
| 41993189 | Association between IL1B rs16944 polymorphism and the risk of idiopathic inflammatory myopathies. | Front Immunol | 2026 | https://conductscience.org/library/papers/41993189 | PubMed |
| 41953221 | Dietary Bazhen San solid-state fermentation product improves laying performance, immunity and intestinal health in laying hens during the late laying period. | Front Immunol | 2025 | https://conductscience.org/library/papers/41953221 | PubMed |
| 41947997 | Novel Pyrazole-3-Cyano-2-Pyridinone Hybrids as Multitarget Anti-Inflammatory Agents: Synthesis, Computational Modeling, and Biological Evaluation. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41947997 | PubMed |
| 41624740 | Interleukin-1β and MicroRNA-146a as Prognostic and Diagnostic Markers of Systemic Lupus Erythematosus Complexity. | Iran J Pathol | 2026 | https://conductscience.org/library/papers/41624740 | PubMed |
| 41090795 | Serum Interleukin-6 in Systemic Lupus Erythematosus: Insights into Immune Dysregulation, Disease Activity, and Clinical Manifestations. | Cells | 2025 | https://conductscience.org/library/papers/41090795 | PubMed |
| 40491969 | New Mechanisms and Therapeutic Targets in Systemic Lupus Erythematosus. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40491969 | PubMed |
| 40430581 | Targeting Hyperuricemia and NLRP3 Inflammasome in Gouty Arthritis: A Preclinical Evaluation of Allopurinol and Disulfiram Combination Therapy. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430581 | PubMed |
| 40352189 | Mechanistic insights into the anticancer, anti-inflammatory, and antioxidant effects of yellowfin tuna collagen peptides using network pharmacology. | Narra J | 2025 | https://conductscience.org/library/papers/40352189 | PubMed |
| 40283912 | Regulation of Intestinal Barrier Function and Gut Microbiota by Hot Melt Extrusion-Drug Delivery System-Prepared Mulberry Anthocyanin in an Inflammatory Bowel Disease Model. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283912 | PubMed |
| 40129871 | Systemic Lupus Erythematosus Stimulates Chondrocyte Pyroptosis to Aggravate Arthritis via Suppression of NRF-2/KEAP-1 and NF-κB Pathway. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40129871 | PubMed |
| 40055311 | Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40055311 | PubMed |
| 40011954 | Blood gene expression of Toll-like receptors in SLE patients with lupus nephritis or neuropsychiatric systemic lupus erythematosus. | Arthritis Res Ther | 2025 | https://conductscience.org/library/papers/40011954 | PubMed |
| 39795014 | Flavonoids, Isoquinoline Alkaloids, and Their Combinations Affect Growth Performance, Inflammatory Status, and Gut Microbiome of Broilers Under High Stocking Density and Heat Stress. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/39795014 | PubMed |
| 39749335 | CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives. | Front Immunol | 2024 | https://conductscience.org/library/papers/39749335 | PubMed |
| 39558370 | Therapeutic effects of extracellular vesicles derived from mesenchymal stem cells primed with disease-conditioned-immune cells in systemic lupus erythematosus. | Arthritis Res Ther | 2024 | https://conductscience.org/library/papers/39558370 | PubMed |
| 39472388 | Systemic lupus erythematosus: pathogenesis and targeted therapy. | Mol Biomed | 2024 | https://conductscience.org/library/papers/39472388 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| ESR2 | 2100 | PubTator's text mining | https://conductscience.org/library/genes/2100 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25548434
GET https://conductscience.org/api/papers/v1/25548434/references?page=2